Similar Papers

Paper Title
Journal
Date
Author
Editors' note: Prospective validation of the PML risk biomarker l -selectin and influence of natalizumab extended intervals
Ariane Lewis
Neurology | VOL. 95
Ariane LewisAriane Lewis
15 Sep 2020
MRI and DTI Characteristics of Natalizumab Associated PML during a Novel Treatment Protocol (P07.061)
A Javed ... M Ko
Neurology | VOL. 78
A Javed, et. al.A Javed ... M Ko
22 Apr 2012
4CPS-062 Positive impact of extending natalizumab dosage interval from every 4 weeks to every 6 weeks in multiple sclerosis patients
O Serna-Romero ... T Cruz-Cruz
European Journal of Hospital Pharmacy | VOL. 31
O Serna-Romero, et. al.O Serna-Romero ... T Cruz-Cruz
01 Mar 2024
Optimizing the Natalizumab Dose Interval to Reduce PML Risk- Lessons from the Pharmacokinetics of Therapy Discontinuation (P4.032)
John Foley ... Ryan Metzger
Neurology | VOL. 84
John Foley, et. al.John Foley ... Ryan Metzger
06 Apr 2015
View more papers

More From: Neurology

Paper Title
Journal
Date
Author
Reader Response: Distribution of Silent Cerebral Infarcts in Adults With Sickle Cell Disease
Calixto Machado
Neurology | VOL. -
Calixto MachadoCalixto Machado
28 Jan 2025
Brain Hypertrophy in Patients With Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis and Its Clinical Correlates
Richard Zubal ... Marian Galovic
Neurology | VOL. 104
Richard Zubal, et. al.Richard Zubal ... Marian Galovic
28 Jan 2025
Reader Response: Wall-Eyed Bilateral Internuclear Ophthalmoplegia Variant Syndrome Caused by Isolated Left Thalamic Infarction.
Eric R Eggenberger
Neurology | VOL. 104
Eric R EggenbergerEric R Eggenberger
28 Jan 2025
Editors' Note: Distribution of Silent Cerebral Infarcts in Adults With Sickle Cell Disease
Aravind Ganesh ... Steven L Galetta
Neurology | VOL. -
Aravind Ganesh, et. al.Aravind Ganesh ... Steven L Galetta
28 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.